Press Releases

Tissue-Specific Features in Humans Revealed Through Cross-Tissue Immune Cell Analysis

In a recent article published, researchers demonstrated tissue-specific immune cell characteristics in humans by performing...

Posted on May 17, 2022 by Admin

High Levels of Short-Lived Antibodies Compared to Natural Infection Induced by Messenger RNA COVID-19 Vaccines

In a recent study, researchers extensively investigated the dynamics of antibodies induced by natural severe...

Posted on May 16, 2022 by Admin

An S1-N Fusion Protein Expressed in An Ad5 Vectored COVID Vaccine

In a recent study, researchers characterized the development of multiple adenovirus-vectored and subunit recombinant protein...

Posted on May 13, 2022 by Admin

SARS-CoV-2 Infections Associated with Two Repatriation Flights from India to Australia have Epidemiologic and Genomic Investigation

To prevent the further spread of coronavirus disease-19 (COVID-19) infection, caused by the severe acute...

Posted on May 12, 2022 by Admin

Against Omicron-Associated Severe Disease Effectiveness of BNT162b2 Third Dose

In a recent study, researchers analyzed the effectiveness of the severe acute respiratory syndrome coronavirus...

Posted on May 11, 2022 by Admin

Serious Neurologic Symptoms Have Found in Approximately 13% of Hospitalized COVID Patients

It has been established that the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes dysfunction...

Posted on May 10, 2022 by Admin

Host Protection Against SARS-CoV-2 Study Suggests Aerosol Transmission of Antibodies may Contribute

Since the onset of the coronavirus disease 2019 (COVID-19) pandemic, caused by the rapid outbreak...

Posted on May 09, 2022 by Admin

Predict the Efficacy of New Coronavirus Vaccines needs Identification of the Immunological Correlate of Protection

In a recent edition, researchers discussed the validity of the equation derived to predict the...

Posted on May 06, 2022 by Admin

Against the SARS-CoV-2 BA.1 and BA.2 Omicron Variants Safety and Immunogenicity of the Pfizer/BioNTech SARS-CoV-2 mRNA Third Booster Vaccine Dose

A recent article reported that the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) booster vaccinations...

Posted on May 04, 2022 by Admin

Against the Omicron Variant of SARS-CoV-2 Study Finds Curcumin is a Potential Therapeutic Agent

A recent study published demonstrated that the phytochemical curcumin is a potent therapeutic prospect against...

Posted on May 02, 2022 by Admin